Overview

Skin Structure Infections With Suspected or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)

Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
To determine if linezolid is superior to vancomycin in the treatment of complicated skin and soft tissue infections due to MRSA in adult subjects
Phase:
Phase 4
Details
Lead Sponsor:
Pfizer
Treatments:
Linezolid
Methicillin
Vancomycin